Table 20.1.3.
Problem | Possible cause | Solution |
---|---|---|
Poor tumor take | Mycoplasma infection of tumor cultures |
Eliminate mycoplasma with ciprofloxacin or thaw vial with fresh tumor sample |
Overtrypsinization of tumor cells |
Dilute out trypsin with large volume of HBSS as soon as tumor cells dislodge; pellet and discard supernatant |
|
Tumor cells not kept on ice | Keep tumor on ice at all time | |
Injected too few tumor cells | Increase inoculum of tumor cells |
|
Poor treatment upon adoptive transfer of CTL |
Low potency or specificity of CTL |
Test CTL in vitro directly prior to transfer to ensure specificity |
Too few CTL transferred | Transfer more CTL, or administer IL-2 |
|
Poor CTL growth | Too little IL-2 in cultures | Prepare new IL-2 stock, check type of units |
Poor FBS quality | Test different FBS lots | |
“Dirty” cultures | Purify on Ficoll to eliminate debris |
|
Over- or understimulation | Restimulate every 7-10 days | |
Overcrowding of culture wells | Split once CTL exceed 50% confluency |
|
Poor CTL specificity/high background (often irreversible) |
Too much IL-2 in cultures | Keep [IL-2] between 30-60 IU/ml |
“Dirty cultures” | Ficoll to eliminate debris | |
Progressive deterioration of specificity, large, granular, fast-growing cells |
Discard culture and thaw new vial or establish new culture from immunized mice |
|
No induction of vitiligo and/or antibodies upon two immunizations with rVVmTRP-1 |
Poor viral titer | Retiter viral stock |
Mixup of rVV stocks | Check expression by immunostaining of infected cells |